医生简介：
医疗特长：肿瘤放射治疗的临床工作及相关研究，包括头颈肿瘤、鼻咽癌、口腔颌面肿瘤，神经系统肿瘤等病种放射治疗、早期诊断、个体化综合治疗、疗效预测、预后及放射损伤研究。头颈肿瘤多项研究发表于国际主流杂志。主持国家自然科学基金、广东省自然科学基金和华南肿瘤学国家重点实验室开放基金多项。研究方向：①头颈肿瘤调强放疗、图像引导放疗及自适应放疗；②头颈肿瘤调强放射治疗个体化照射范围；③头颈部正常组织的放射损伤及防护。主要教育和工作经历：1996-09至2001-06 中山医科大学临床医学学士学位2001-09至2004-06 中山大学肿瘤防治中心肿瘤学硕士学位2008-09至2011-06 中山大学肿瘤防治中心肿瘤学博士学位2004-07至2008-08 云南省肿瘤医院放射治疗科医师2011-07至现在 中山大学附属第一医院放射治疗科住院/主治/副主任医师社会兼职：广州市抗癌协会肿瘤放射治疗专业委员会委员论著：1. Shen GP#, Pan QH#, Hong MH#, Qin HD, Xu YF, Chen LZ, Feng QS, Jorgensen TJ, Shugart YY, Zeng YX, Jia WH. Human genetic variants of homologous recombination repair genes first found to be associated with Epstein-Barr virus antibody titers in healthy Cantonese. Int J Cancer. 2011 Sep 15;129(6):1459-66. (IF=5.4)2. Shen GP, Xu FH, He F, Ruan HL, Cui C, Chen LZ, Zeng YX, Jia WH. Pretreatment lifestyle behaviors as survival predictors for patients with nasopharyngeal carcinoma. PLoS One. 2012;7(5):e36515. (IF=3.7)3. He JR#, Shen GP#, Ren ZF, Qin H, Cui C, Zhang Y, Zeng YX, Jia WH. Pretreatment levels of peripheral neutrophils and lymphocytes as independent prognostic factors in patients with nasopharyngeal carcinoma. Head Neck. 2012 Dec;34(12):1769-76. (IF=2.8)4. Zhang MX#, Li J#, Shen GP#, Zou X, Xu JJ, Jiang R, You R, Hua YJ, Sun Y, Ma J, Hong MH, Chen MY. Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up. Eur J Cancer. 2015 Aug 26.(IF=6.1)
